Conference Menu
Current Event
2008 Overview
Pre-Conference Tutorial
Day 1
Day 2
PDF Download
Press Pass
Request Brochure
Complimentary White Paper
21st Century Pharma: Managing Current Challenges to Ensure Future Growth
Stay on for the Third Annual
Portfolio Management Executive Forum
November 18-19, 2008
Philadelphia, PA
Supporting Association
Corporate Sponsors
Corporate Support Sponsor:
Lead Sponsoring Publications:
Media Partners:
|
|
|
|
|
- Speaker Presentations
- Poster Abstracts
- and More!
|
Bring Your Entire Team!
Contact Call David Cunningham at 781.972.5472 for group discounts and company rates.
|
Utilizing Corporate Portfolio Management to Stop Investile Dysfunction
 Anand Sanwal, Managing Director, Brilliont; Former VP, Investment Optimization & Strategic Business Analysis, American Express
|
Portfolio Management in the Pharmaceutical Commercialization Space
 Poplin Kroese, Senior Analyst, Portfolio Management Strategy Deployment, Merck
|
Integrating Value into the Portfolio Decision-Making Framework
 Jean Lee, Director, WWD Portfolio Management, Pfizer; Co-developed with Lori S. Shafner, Vice President, Portfolio and Project Management, Pfizer |
Valuing a Diverse Portfolio: The Move from Selling Medicines to Promoting Health
 Marilyn Metcalf, Ph.D., Director, Quantitative and Decision Sciences, GlaxoSmithKline |
Evolution of Resource Management Capability at a Large Biotechnology Company
 Matthew Riddell, M.B.A., Associate Director, Research & Development Planning & Operations, Program & Alliance Management, Biogen Idec
|
Cost-Risk-Value Optimization – Enabling Drug Developers to “Do the right thing”
 Stephen A. Williams, Ph.D., Partner, Decisionability LLC; Former Vice President and Worldwide Head of Clinical Technology, Pfizer
|
Strategic Resource Management: Go Beyond Fancy Charts and Truly Impact Strategic Business Decisions
Christopher Beck, Vice President, Program Resources and Decision Support, Shire Pharmaceuticals
|
Successful Portfolio Management within Discovery at AstraZeneca
 Richard Lawson, Ph.D., Global Head of Discovery Decision Support, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.
|
Development Program Prioritization-Allocating Limited Resources in Any Business Environment
 Len Falsone, PE, Economics Manager, EP Americas, Shell Exlporation and Production Company |
Aligning Strategic Capacity Management with Business Development in Healthcare Product Safety
 Colin Cornhill, Senior Director, BRM Integration & Capacity Management, Johnson & Johnson Pharmaceutical R&D
|
Distinguished Faculty:
- Murray Aitken, Senior Vice President, Healthcare Insight, IMS Health Inc.
- Richard M. Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation; Faculty, University of Pennsylvania
- Sabine Bernotat-Danielowski, Ph.D., MBA, Executive Director, Decision Analysis, Daiichi Sankyo
- Robin G. Foldesy, Ph.D., Vice President, Portfolio Management, Wyeth Research
- Richard J. Heaslip, Ph.D., Vice President, Project & Portfolio Management, Wyeth Research
- Peter Heinrich, Ph.D., CEO, Portfolio DecisionWare, Inc.
- Jeff Hewitt, Senior Principal, SDG life sciences, a unit of IMS
- Jennifer Hirsch, Associate Director, R&D Operations, Johnson & Johnson Pharmaceutical R&D
- J. Mark Horn, Director, Finance and R&D Portfolio Management, Wyeth Consumer Healthcare
- John I. Howell III, President, Portfolio Decisions, Inc.
- Matthew Kiernan, Partner, Pharmica Consulting
- Poplin Kroese, Senior Analyst, Portfolio Management Strategy Deployment, Merck & Co.
- Maureen Martini, Senior Project Manager, Global Strategic Planning and Program Management, Shire Pharmaceuticals
- Grant Morgan, Ph.D., PMP, Leader of R&D Metrics and Capacity Management, Allergan, Inc.
- Chad Nikel, Director of Business Development, Integrated Project Management
- Paul Ranky, Ph.D., Professor, Department of Industrial and Management Systems Engineering and IT, NJIT
- James F. Resch, Ph.D., Director, Strategic Intelligence, Discovery Strategy and Performance, AstraZeneca
- Otto Ritter, Ph.D., Associate Director, Global Discovery Information, AstraZeneca
- Vladimir Shnaydman, Ph.D, President, ORBee Consulting
- Michael Shulman, Editor/Analyst, ChangeWave
- Daniel Smith, Vice President, Enrich Consulting
- Lillian Warren, Chief Operating Officer, Portfolio Decisions, Inc.
PRE-CONFERENCE TUTORIAL
EFFECTIVE STRATEGIC PLANNING FOR R&D PROFESSIONALS
* Separate registration is required.
Applications in Optimization of Strategic Planning – Portfolio Selection, Capacity Planning, and Scheduling of Portfolio of Projects
 Vladimir Shnaydman, Ph.D., ORBee Consulting
The workshop will be focused on effective solutions to challenging problems in corporate strategic planning. Our solutions are based on optimization methodology because traditional planning approaches face serious limitations. Click here for details
Overview | Tutorial | Day 1 | Day 2
|
|
|